Home » NOVELOS INITIATES OVARIAN CANCER TREATMENT TRIAL
NOVELOS INITIATES OVARIAN CANCER TREATMENT TRIAL
Novelos Therapeutics announced that Partners Cancer Care has enrolled the first patient in a Phase II trial of NOV-002 in combination with carboplatin in platinum-resistant ovarian cancer patients.
The primary objective of this open-label, single-arm trial will be to determine the tumor response rate in women with platinum-resistant ovarian cancer after treatment with NOV-002 and carboplatin. Up to 25 women will be enrolled in the trial, and they may receive up to six cycles of treatment. Interim results are expected in early 2007.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May